In lung adenocarcinoma, USP22, adeubiquitinase highly overexpressed in multiple cancer types, has been shown tomodulate PALB2 levels through its C-terminal WD40 domain to promotechemoresistance (31). The gene discussed is USP22; the disease is lung adenocarcinoma.